David Li

3.9k total citations · 2 hit papers
76 papers, 3.0k citations indexed

About

David Li is a scholar working on Surgery, Surfaces, Coatings and Films and Biomedical Engineering. According to data from OpenAlex, David Li has authored 76 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 13 papers in Surfaces, Coatings and Films and 13 papers in Biomedical Engineering. Recurrent topics in David Li's work include Transplantation: Methods and Outcomes (13 papers), Surface Modification and Superhydrophobicity (13 papers) and Multiple Sclerosis Research Studies (9 papers). David Li is often cited by papers focused on Transplantation: Methods and Outcomes (13 papers), Surface Modification and Superhydrophobicity (13 papers) and Multiple Sclerosis Research Studies (9 papers). David Li collaborates with scholars based in Canada, United States and Germany. David Li's co-authors include A. W. Neumann, Y. Rotenberg, L. Borůvka, Ping Cheng, Ludwig Kappos, Stephen L. Hauser, Peter A. Calabresi, Paul O’Connor, David Leppert and Frederik Barkhof and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

David Li

73 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

2011 538 citations Ludwig Kappos, David Li et al. The Lancet profile →
Automation of axisymmetric drop shape analysis for measurements of interfacial tensions and contact angles

1990 447 citations David Li, A. W. Neumann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Li Canada	28	650	596	533	386	343	76	3.0k
Xiang Yan China	25	745 1.1×	141 0.2×	472 0.9×	249 0.6×	233 0.7×	142	3.0k
John C. Chen United States	36	637 1.0×	142 0.2×	1.2k 2.2×	361 0.9×	478 1.4×	159	5.3k
Yin Ding China	41	220 0.3×	125 0.2×	1.2k 2.2×	72 0.2×	191 0.6×	172	5.7k
David N. Ku United States	46	114 0.2×	237 0.4×	2.1k 3.9×	131 0.3×	153 0.4×	182	10.5k
Hongyu Yu China	40	177 0.3×	120 0.2×	2.8k 5.2×	224 0.6×	1.8k 5.2×	312	7.0k
Lei Jiang China	29	296 0.5×	84 0.1×	616 1.2×	78 0.2×	130 0.4×	182	3.4k
Zhe Li China	26	202 0.3×	49 0.1×	452 0.8×	84 0.2×	220 0.6×	98	3.0k
Xiaofang Zhang China	35	1.0k 1.6×	69 0.1×	1.2k 2.2×	290 0.8×	880 2.6×	191	4.3k
Masato Sato Japan	41	148 0.2×	1.1k 1.9×	1.2k 2.2×	107 0.3×	668 1.9×	333	6.6k
Hua Li China	37	101 0.2×	82 0.1×	716 1.3×	326 0.8×	1.3k 3.8×	208	4.6k

Countries citing papers authored by David Li

Since Specialization

Citations

This map shows the geographic impact of David Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Li more than expected).

Fields of papers citing papers by David Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Li. The network helps show where David Li may publish in the future.

Co-authorship network of co-authors of David Li

This figure shows the co-authorship network connecting the top 25 collaborators of David Li. A scholar is included among the top collaborators of David Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Li. David Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Kun, et al.. (2025). A method for extracting water surface and hydrophytic vegetation from ICESat-2 data in wetlands. SHILAP Revista de lepidopterología. 17. 100097–100097.

Ouyang, Lijun, David Li, Zongchang Li, et al.. (2022). IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals. Frontiers in Psychiatry. 13. 1072380–1072380. 14 indexed citations

Wei, Jinchi, David Li, David C. Sing, et al.. (2022). Detecting total hip arthroplasty dislocations using deep learning: clinical and Internet validation. Emergency Radiology. 29(5). 801–808. 7 indexed citations

Cook, Aaron M., et al.. (2022). Prevalence and prediction of augmented renal clearance in the neurocritical care population. SHILAP Revista de lepidopterología. 15(2). 96–103. 3 indexed citations

Li, David, J. Weinkauf, A. Kapasi, et al.. (2021). Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation. Respiratory Medicine. 188. 106617–106617. 25 indexed citations

Li, David, Qiuli Duan, J. Weinkauf, et al.. (2020). Azithromycin prophylaxis after lung transplantation is associated with improved overall survival. The Journal of Heart and Lung Transplantation. 39(12). 1426–1434. 15 indexed citations

Rajendran, Luckshi, et al.. (2019). Three-dimensional MRI sequences in MS diagnosis and research. Multiple Sclerosis Journal. 25(13). 1700–1709. 9 indexed citations

Li, David, J. Weinkauf, A. Hirji, et al.. (2019). Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients. The Journal of Heart and Lung Transplantation. 38(7). 710–718. 10 indexed citations

Kolind, Shannon, Irene M. Vavasour, Lisa Tang, et al.. (2017). Advanced Myelin-related MRI Measures in Relapsing Multiple Sclerosis Patients treated with Ocrelizumab or Interferon Beta-1a Over 96 Weeks (P6.371). Neurology. 88(16_supplement). 3 indexed citations

10.

Durr, Megan L., David Li, & Steven J. Wang. (2013). Oral cavity squamous cell carcinoma in never smokers: Analysis of clinicopathologic characteristics and survival. American Journal of Otolaryngology. 34(5). 388–393. 27 indexed citations

11.

Hauser, Stephen L., David Li, Peter A. Calabresi, et al.. (2013). Week 144 Results of a Phase II, Randomized, Multicenter Trial Assessing the Safety and Efficacy of Ocrelizumab in Patients with Relapsing–Remitting Multiple Sclerosis (RRMS) (S31.004). Neurology. 80(7_supplement). 9 indexed citations

12.

Durr, Megan L., Annemieke van Zante, David Li, Eric J. Kezirian, & Steven J. Wang. (2013). Oral Tongue Squamous Cell Carcinoma in Never‐Smokers: Analysis of Clinicopathologic Characteristics and Survival. Otolaryngology. 149(1). 89–96. 36 indexed citations

13.

Kappos, Ludwig, David Li, Peter A. Calabresi, et al.. (2011). Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. The Lancet. 378(9805). 1779–1787. 538 indexed citations breakdown →

14.

Ebers, George C., Anthony T. Reder, Anthony Traboulsee, et al.. (2009). Long-term follow-up of the original interferon-β1b trial in multiple sclerosis: Design and lessons from a 16-year observational study. Clinical Therapeutics. 31(8). 1724–1736. 27 indexed citations

15.

Li, David, Witold Pedrycz, & Nick J. Pizzi. (2005). Fuzzy Wavelet Packet Based Feature Extraction Method and Its Application to Biomedical Signal Classification. IEEE Transactions on Biomedical Engineering. 52(6). 1132–1139. 57 indexed citations

16.

Xiang, Qing, et al.. (2005). Real Time PCR on Disposable PDMS Chip with a Miniaturized Thermal Cycler. Biomedical Microdevices. 7(4). 273–279. 75 indexed citations

17.

Zuo, Yi Y., et al.. (2004). Further development of Axisymmetric Drop Shape Analysis-Captive Bubble for pulmonary surfactant related studies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1675(1-3). 12–20. 32 indexed citations

18.

Yu, Laura M.Y., et al.. (2002). The effect of dextran to restore the activity of pulmonary surfactant inhibited by albumin. Respiratory Physiology & Neurobiology. 130(2). 169–179. 40 indexed citations

19.

Freeman, Hugh James, et al.. (1995). Laminated Intestinal Calculi – A Rare Complication of Crohn′s Disease. Canadian Journal of Gastroenterology and Hepatology. 9(1). 13–16. 1 indexed citations

20.

Li, David & A. W. Neumann. (1994). Phase rule for capillary systems. Advances in Colloid and Interface Science. 49. 147–195. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact